Biodesix, Inc.
BDSX • NASDAQ
Biodesix, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Scott Hutton, with a market cap of $140.1M.
Market Cap$140.1M
Employees217.0
CEOScott Hutton
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Biodesix, Inc. FAQ
Common questions about Biodesix, Inc.
Biodesix, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $22.9M.
Biodesix, Inc. has approximately 217 employees.